Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells

Multiple myeloma is the second most prevalent type of blood cancer, representing approximately 1% of all cancers and 2% of all cancer deaths. There is therefore a strong need to identify critical targets in multiple myeloma neoplasia and progression. Cancerous inhibitor of PP2A (CIP2A) is a human on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi, Zhang, Yaping, Liu, Hong, Lin, Zenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837246/
https://www.ncbi.nlm.nih.gov/pubmed/27144172
http://dx.doi.org/10.1155/2016/6864135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837246/
https://www.ncbi.nlm.nih.gov/pubmed/27144172
http://dx.doi.org/10.1155/2016/6864135

Ejemplares similares